A study published in the journal Modern Research in Inflammation found that intravenous (IV) vitamin C therapy decreased inflammatory markers in rheumatoid arthritis (RA) patients.

The patients in this study were characterized by moderate to high levels of the inflammatory marker C-reactive protein (CRP).

The scientists found that varying doses of IV vitamin C — from 7.5 to 50 grams — reduce both pain as well as inflammatory markers in the bloodstream of the subjects.

The average CRP level before treatment was high at 9.4 mg/L (normal is less than 3 mg/L). After intravenous vitamin C therapy, CRP declined to 6.4 mg/L. The subjects were given between 4 and 30 IVs of vitamin C.

In fact, vitamin C IV therapies have been used to successfully treat many illnesses for nearly 100 years. Vitamin C reduces inflammation and heals injured tissue.

It also supports collagen formation, and enhances extracellular protein synthesis.

Most patients with chronic illnesses, RA included, are found to be deficient in vitamin C, which is an essential nutrient that we cannot manufacture in our bodies.

Simply put, we must get vitamin C from our food supply or we will fall ill and die.

Unfortunately, the levels of vitamin C in food have been steadily declining for 20 years.

Oral dosing of vitamin C can help nearly any condition. I suggest 3,000 to 5,000 mg per day. For those with severe illnesses, vitamin C IVs can make dramatic changes in chronic disease. They are both extremely safe and very effective.

It is too bad that these things are not taught in medical schools.